David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 7,500 shares at $3.15 ($24K) on 2011-09-14, disclosed to the SEC on 2011-09-15.
Open-market purchase of $24k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.15 | 200 | $630 | 2.6% |
| 2 | $3.16 | 1,800 | $6K | 23.9% |
| 3 | $3.18 | 5,500 | $17K | 73.5% |
| Total | $3.17 avg | 7,500 | $24K | 100% |
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |